Novel Fas/CD95 Signaling Mechanisms
Novel Fas/CD95 Signaling Mechanisms
批准号:
7589350
负责人:
Marcus E. Peter
金额:
$27.57万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-27 至 2012-07-31
关键词:
AddressAffectApoptosisApoptoticAutomobile DrivingCASP8 and FADD-like apoptosis regulating proteinCD95 AntigensCell surfaceCellsCessation of lifeCharacteristicsChoices and ControlComplexConditionCysteineDevelopmentDiseaseDown-RegulationEmployee StrikesEventGenesHMGA2 geneIn VitroInvasiveLigandsMalignant NeoplasmsMalignant neoplasm of ovaryMediatingMediator of activation proteinMicroRNAsModelingModificationMolecular WeightNumbersPathway interactionsPost-Translational Protein ProcessingProcessProtein Tyrosine KinaseProtein Tyrosine PhosphatasePublic HealthReceptor SignalingRegulationReportingResistanceRoleSignal PathwaySignal TransductionSiteSystemTestingTherapeuticTissuesTyrosinebasecancer cellcaspase-8cell killingcell motilitydesignmouse modelmutantneoplastic cellnovelnovel therapeuticspalmitoylationreceptor internalizationresearch studyresponsetherapeutic targettumortumor growthtumor progressiontumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The death receptor Fas (CD95/APO-1) mediates apoptosis in many tissues. Upon stimulation by its ligand FasL, it forms a death inducing signaling complex (DISC) consisting of the adaptor molecule FADD, the initiator caspases 8 and 10, and the caspase-8/10 regulator c-FLIP. Recently it has become clear that, in addition to its role as a death receptor, Fas has multiple nonapoptotic activities including a role in rendering Fas apoptosis-resistant cancer cells more mobile and invasive. These novel activities also rely on DISC components, raising the question of how the choice to engage apoptotic or nonapoptotic signaling pathways is made. We have recently shown that Fas requires internalization into an endosomal/lysosomal compartment in order to signal apoptosis. However, in striking contrast, we found that receptor internalization is not required for nonapoptotic signaling through Fas. We found that tyrosine 291 is involved in regulating the internalization of Fas and that another postranslational modification, palmitoylation of cysteine 199, facilitates the formation of high molecular weight DISC complexes (hiDISC). hiDISC forms at the sites of Fas internalization. Recently, we found that Fas suppresses the expression of the microRNA let-7 and we obtained evidence that let-7 drives tumor progression through targeting HMGA2 and IMP-1. We hypothesize that the two posttranslational modifications of Fas determine whether Fas is internalized and whether it activates apoptotic or nonapoptotic signaling pathways resulting in downregulation of let-7. Identification of the role and the mechanisms of the internalization of Fas, its regulation by posttranslational modifications, and the regulation of let-7 expression by Fas could provide the means to neutralize the tumor promoting activities of Fas. We propose the following three specific aims: Aim 1: Determine the mechanisms that regulate whether Fas signals apoptosis or survival. Aim 2: Characterize the functional connection between Fas and let-7. Aim 3: Elucidate the function of Fas signaling mutants and of Fas regulated miRNAs in mouse models of ovarian cancer. Characterization of the novel mechanisms and functional consequences of nonapoptotic signaling of Fas may facilitate the development of rational strategies and therapeutic approaches for interfering with dysregulated Fas signaling in cancer and other diseases. PUBLIC HEALTH RELEVANCE: The death receptor Fas (CD95/APO-1) has been viewed as a mediator of apoptosis in many tissues but it has become clear that Fas has multiple nonapoptotic activities including the induction of proliferation and tumor invasiveness. We will study the early events of Fas signaling including receptor internalization that determine whether Fas signals apoptotic or nonapoptotic pathways and downregulation of tumor suppressing microRNAs. These studies will provide a basis for understanding the different signaling activities of Fas and to devise new therapeutic approaches for interfering with dysregulated Fas signaling in cancer and other diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
-
批准号:10514907
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2022
-
负责人:Marcus E. Peter
-
依托单位:
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
-
批准号:10661817
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2022
-
负责人:Marcus E. Peter
-
依托单位:
6mer seed toxicity and AIDS
-
批准号:10132980
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2020
-
负责人:Marcus E. Peter
-
依托单位:
Fas protects cancer stem cells from death
-
批准号:8891918
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9313238
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9753713
-
项目类别:
-
资助金额:$88.65万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DISE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:10224839
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
DICE - a natural cancer surveillance mechanism - a new road to cancer therapy
-
批准号:9122387
-
项目类别:
-
资助金额:$91.4万
-
财政年份:2015
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8187162
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8528496
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7250259
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7452329
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8698714
-
项目类别:
-
资助金额:$28.53万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7122337
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:6970354
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The Role of CD95 as a Tumor Promoter
-
批准号:7623183
-
项目类别:
-
资助金额:$28.84万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
The role of Fas as tumor promoter
-
批准号:8306703
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2005
-
负责人:Marcus E. Peter
-
依托单位:
Novel CD95 Signaling Mechanisms
-
批准号:7098097
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
Novel CD95 Signaling Mechanisms
-
批准号:6795872
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
Novel Fas/CD95 Signaling Mechanisms
-
批准号:7688490
-
项目类别:
-
资助金额:$27.57万
-
财政年份:2002
-
负责人:Marcus E. Peter
-
依托单位:
海外基金